Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "HIK"


4 mentions found


HAWSTON, South Africa (AP) — Nearly every house in Hawston has a boat in its yard, sometimes two. It's reduced the endangered South African abalone to unprecedented low levels, wildlife groups say. Political Cartoons View All 1256 ImagesAt first, the South African government banned abalone fishing completely. Hong Kong is importing between 2,000-3,000 metric tons of illegal South African abalone a year, the report estimated. Chan also rates South African abalone highly, as so many do, with its rich taste and slightly chewy texture.
Persons: Raphael Fisher, perlemoen, Fisher, , “ It’s, Wendy Chan, Chan, , Keet, It's, Bertus van, van Oordt, Van Oordt, we'll, ” van Oordt, “ We'll, Markus Burgener, ” Burgener, Burgener, Zara, Toby, ” Fisher, Kanis Leung, Alice Fung Organizations: South, Global, Transnational, International Union for Conservation, Nature, Divers, Lookouts, Trade Monitoring, AP Locations: South Africa, Hawston, East Asia, Hong Kong, China, Japan, Taiwan, Gansbaai, HIK, Hawston's, Africa, africa
Sandoz owners are banking on margin cure
  + stars: | 2023-10-04 | by ( ) www.reuters.com   time to read: +2 min
LONDON, Oct 4 (Reuters Breakingviews) - Sandoz’s (SDZ.S) investors are giving CEO Richard Saynor the benefit of the doubt. Shares in the generics drug maker, which $217 billion pharma giant Novartis (NOVN.S) has finally managed to spin off, started to trade in Zurich on Wednesday. There was a risk that Novartis investors, who have long called for a sale or spinoff, would quickly dump the new Sandoz shares. At current market prices, Sandoz is worth nearly $11 billion, or $14.4 billion once net debt is added in. For now, Novartis investors seem to believe Sandoz’s treatment may be effective.
Persons: Richard Saynor, Sandoz, Aimee Donnellan, Lisa Jucca, Streisand Neto Organizations: Reuters, Novartis, Sandoz, Hikma Pharmaceuticals, X, Brookfield pounces, Temasek, Thomson Locations: Zurich, That’s
Hikma shares rose by as much as 9.4% in their largest one-day increase since last September. Pfizer is the largest supplier in the U.S. injectables market and Hikma is the second-largest, analysts said. Hikma, which has a market value of around $5.6 billion compared with Pfizer's $205.7 billion, might struggle to meet demand, Herrmann said. European healthcare stocks (.SXDP) were up around 0.7% on the day, outperforming the broader STOXX 600 (.STOXX), which rose 0.4%. Pfizer shares were up 0.16% in premarket trading.
Persons: Fresenius, Max Herrmann, Herrmann, Hikma, Amanda Cooper, Jan Harvey Organizations: Pfizer, Reuters, Thomson Locations: U.S, Rocky Mount, North Carolina, Hikma
Nearly 25 percent of all sterile injectables used in U.S. hospitals are produced at the Rocky Mount facility, according to Pfizer's website. Hikma shares rose by as much as 9.4% in their largest one-day increase since last September, hitting an 18-month high. Pfizer is the largest supplier in the U.S. injectables market and Hikma is the second-largest, analysts said. Hikma has a market value of around $5.6 billion, compared with Pfizer's $205.7 billion and Fresenius SE's $16.7 billion, according to Refinitiv data. Pfizer shares were up 0.16% in premarket trading.
Persons: Fresenius, Max Herrmann, Herrmann, Hikma, J.P.Morgan, Amanda Cooper, Jan Harvey, Mike Harrison Organizations: Pfizer, Rocky, U.S . Food, Drug Administration, Thomson Locations: U.S, Rocky Mount, North Carolina, Hikma
Total: 4